subscribe: Posts | Comments

Tanzanian scientist wins Pfizer Award for sickle-cell research

0 comments

Summary of story from the New Statesman, January 19, 2012

Tanzanian-born Julie Makani has been presented with the Royal Society Pfizer Award for her research into sickle-cell disease.

In the last decade she has also became a Wellcome Trust fellow, gained a PhD, been awarded a place on Archbishop Tutu’s Leadership Fellowship Programme, as well as worked in her native Africa with women and children with sickle-cell disease.

Makani decided to become a doctor at a young age. Growing up, she lived in a region where sickle-cell disease was prevalent; three of her five cousins died from the condition.

“It can be overwhelming,” Makani says about working in Africa, “when you’re dealing with all the patients, with very few resources… you need lots of perseverance, to be tough. And you definitely need to be optimistic.”

In Tanzania, about 8,000 to 11,000 children are born every year with sickle-cell disease and the majority don’t know they have it, so up to 90 per cent are not likely to survive into adulthood.

In 2010, it was 100 years since the disease was discovered – and there is only one drug licensed for use.

Makani calls it a tragedy that the pharmaceutical company Pfizer earned revenue of $68bn in 2010 but invested minimal amounts into research and development in third world countries like Africa.

She says she is very much aware that the profession is dominated by men, and describes the UK scientific community as patriarchal, saying: “It’s tough, very challenging.”

She praises female mentors who understand and demonstrate how to balance family life with work. “This then allows me perspective and the ability to focus on important things.”

She also warns how success in the academic and research fields can lead to a departure from more ‘hands on’ work.

“You find as an African that, by the time you finish your PhD, you are asked to take on these new roles on committees or as a department head, which is good, but also bad because it takes you away from science.”

The 41-year-old said she would really like to retire at 50 and run centres of excellence in Tanzania where she can train the next generation of scientists.

Leave a Reply

Your email address will not be published. Required fields are marked *